Clinical Trials Logo

Clinical Trial Summary

Scientific research focuses on "eosinophilic inflammation" as it seems to guide the therapeutic regimen in patients with asthma and COPD. The primary objective of this prospective trial is to evaluate which parameter(s) best reflects eosinophilic inflammation by correlating tissue eosinophils (endobronchial biopsy, protected specimen brush sampling) with FeNO, peripheral blood eosinophils, and eosinophils in the bronchoalveolar lavage of patients with obstructive pulmonary disease.


Clinical Trial Description

This is a multicenter prospective trial. Enrollment will continue until 150 patients with chronic obstructive pulmonary disease and 50 patients with severe asthma have been entered into this trial and have completed bronchoscopic evaluation. In this trial, the following parameters are to be evaluated: - Blood eosinophils (absolute and relative) - FeNO - Eosinophils in bronchoalveolar lavage - Tissue eosinophilia (protected specimen brush sampling, endobronchial biopsy) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03845257
Study type Observational
Source Heidelberg University
Contact
Status Terminated
Phase
Start date February 14, 2019
Completion date January 8, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05595733 - Can NAVA Mode Reduce Mechanical Ventilation Day in Patients With COPD ? N/A
Completed NCT02506504 - Prevention of Post-exercise Muscle Fatigue and Effect on Exercise Training in Severe Patients With COPD. N/A
Completed NCT02290535 - Electrical Impedance Tomography of Lung in Child and Young Age N/A
Active, not recruiting NCT02073708 - A Population-based Investigation of Asthma in the Telemark Region of Norway